Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity"
- PMID: 31922053
- PMCID: PMC6951440
- DOI: 10.3233/NHA-190068
Reply to critique of "A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity"
Abstract
This article is an invited response to a critique by industry of our published study about the impact of carrageenan supplement on the interval to relapse in ulcerative colitis patients on a no-carrageenan diet.
Keywords: Carrageenan; inflammation; log-rank test; ulcerative colitis.
Conflict of interest statement
Conflict of interest The authors have no conflict of interest to report.
Figures
Comment on
-
A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity.Nutr Healthy Aging. 2017 Mar 31;4(2):181-192. doi: 10.3233/NHA-170023. Nutr Healthy Aging. 2017. PMID: 28447072 Free PMC article.
References
-
- Tobacman JK. The common food additive carrageenan and the alpha-gal epitope. J Allergy Clin Immunol. 2015;136(6): 1708–9. - PubMed
-
- Bhattacharyya S, O-Sullivan I, Katyal S, Unterman T, Tobacman JK. Exposure to the common food additive carrageenan leads to glucose intolerance, insulin resistance and inhibition of insulin signalling in HepG2 cells and C57BL/6J mice. Diabetologia. 2012;55(1):194–203. - PubMed
-
- Marinalg Working Group on Molecular Weight Determination. Technical position on measurements related to meeting the EC molecular weight distribution specification for carrageenan and PES. Report Jan 2006. https://wwwcornucopia.org/wp-content/uploads/2016/04/CarageenanReport-20...
-
- Proposed Revision of Food Additive Regulations and Deletion of Chondrus Extract (Carrageenin) from Generally Regarded as Safe (GRAS) List. 37 Fed Reg 15434. 1, 1972.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources